DHX30 Polyclonal antibody, PBS Only

DHX30 Polyclonal Antibody for WB, Indirect ELISA
Cat No. 28814-1-PBS

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, Indirect ELISA

ATP-dependent RNA helicase DHX30, DDX30, DEAH box protein 30, EC:3.6.4.13, KIAA0890

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Product Information

28814-1-PBS targets DHX30 in WB, Indirect ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag29885

Product name: Recombinant human DHX30 protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 336-501 aa of BC014237

Sequence: QVRQGKVTRQGKFKPNSVTYRTKSGNILLHKSTINREATRLRSRWLTYFMAVKSNGSVFVRDSSQVHPLAVLLLTDGDVHIRDDGRRATISLSDSDLLRLEGDSRTVWLLKELRRALGRMVERSLRSELAALPPSVQEEHGQLLALLAELLRGPCGSFDVRKTADD

Predict reactive species
Full Name DEAH (Asp-Glu-Ala-His) box polypeptide 30
Calculated Molecular Weight 501 aa, 56 kDa
Observed Molecular Weight 134 kDa
GenBank Accession NumberBC014237
Gene Symbol DHX30
Gene ID (NCBI) 22907
RRIDAB_2881216
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ7L2E3
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

The DHX30 protein is a crucial member of the DEAH-box RNA helicase family, localized in both the cytoplasm and mitochondria. As a key regulator of RNA metabolism, it hydrolyzes ATP to unwind RNA secondary structures or RNA-protein complexes, thereby playing a central role in fundamental cellular processes such as ribosome biogenesis, mitochondrial translation initiation, and the regulation of mRNA stability. This protein is particularly prominent in the nervous system, where mutations in its encoding gene have been clearly identified as one of the genetic factors leading to neurodevelopmental disorders (such as autism spectrum disorder and intellectual disability), primarily affecting neuronal differentiation and synaptic function. In recent years, studies have also found that DHX30 is abnormally expressed in various cancer tissues, suggesting its potential involvement in tumor development and progression, making it a promising tumor biomarker and therapeutic target.

Loading...
||
New chat Able
正在加载,请稍候...